485 related articles for article (PubMed ID: 27705010)
21. Modeling listener perception of speaker similarity in dysarthria.
Lansford KL; Berisha V; Utianski RL
J Acoust Soc Am; 2016 Jun; 139(6):EL209. PubMed ID: 27369174
[TBL] [Abstract][Full Text] [Related]
22. The short- and long-term effectiveness of the LSVT for dysarthria following TBI and stroke.
Wenke RJ; Theodoros D; Cornwell P
Brain Inj; 2008 Apr; 22(4):339-52. PubMed ID: 18365848
[TBL] [Abstract][Full Text] [Related]
23. Speech treatment for Hebrew-speaking adolescents and young adults with developmental dysarthria: A comparison of mSIT and Beatalk.
Carl M; Levy ES; Icht M
Int J Lang Commun Disord; 2022 May; 57(3):660-679. PubMed ID: 35363414
[TBL] [Abstract][Full Text] [Related]
24. Changes in voice quality after speech-language therapy intervention in older children with cerebral palsy.
Miller N; Pennington L; Robson S; Roelant E; Steen N; Lombardo E
Folia Phoniatr Logop; 2013; 65(4):200-7. PubMed ID: 24503934
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Lee Silverman Voice Treatment (LSVT) on hypernasality in non-progressive dysarthria: the need for further research.
Wenke RJ; Theodoros D; Cornwell P
Int J Lang Commun Disord; 2010; 45(1):31-46. PubMed ID: 19565392
[TBL] [Abstract][Full Text] [Related]
26. Data-Driven Classification of Dysarthria Profiles in Children With Cerebral Palsy.
Allison KM; Hustad KC
J Speech Lang Hear Res; 2018 Dec; 61(12):2837-2853. PubMed ID: 30481827
[TBL] [Abstract][Full Text] [Related]
27. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
Sauvageau VM; Roy JP; Langlois M; Macoir J
Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
[TBL] [Abstract][Full Text] [Related]
28. Using Crowdsourced Listeners' Ratings to Measure Speech Changes in Hypokinetic Dysarthria: A Proof-of-Concept Study.
Nightingale C; Swartz M; Ramig LO; McAllister T
Am J Speech Lang Pathol; 2020 May; 29(2):873-882. PubMed ID: 32331503
[TBL] [Abstract][Full Text] [Related]
29. Sentence stress in children with dysarthria and cerebral palsy.
Kuschmann A; Lowit A
Int J Speech Lang Pathol; 2019 Aug; 21(4):336-346. PubMed ID: 29516763
[No Abstract] [Full Text] [Related]
30. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
[TBL] [Abstract][Full Text] [Related]
31. Intensive treatment of dysarthria in two adults with Down syndrome.
Mahler LA; Jones HN
Dev Neurorehabil; 2012; 15(1):44-53. PubMed ID: 22256834
[TBL] [Abstract][Full Text] [Related]
32. Voice in Friedreich Ataxia.
Vogel AP; Wardrop MI; Folker JE; Synofzik M; Corben LA; Delatycki MB; Awan SN
J Voice; 2017 Mar; 31(2):243.e9-243.e19. PubMed ID: 27501923
[TBL] [Abstract][Full Text] [Related]
33. Dysarthria in Mandarin-Speaking Children With Cerebral Palsy: Speech Subsystem Profiles.
Chen LM; Hustad KC; Kent RD; Lin YC
J Speech Lang Hear Res; 2018 Mar; 61(3):525-548. PubMed ID: 29471380
[TBL] [Abstract][Full Text] [Related]
34. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
[TBL] [Abstract][Full Text] [Related]
35. Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.
Miles A; Jardine M; Johnston F; de Lisle M; Friary P; Allen J
J Neurol Sci; 2017 Dec; 383():180-187. PubMed ID: 29246611
[TBL] [Abstract][Full Text] [Related]
36. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
[TBL] [Abstract][Full Text] [Related]
37. Changes in brain activity following intensive voice treatment in children with cerebral palsy.
Bakhtiari R; Cummine J; Reed A; Fox CM; Chouinard B; Cribben I; Boliek CA
Hum Brain Mapp; 2017 Sep; 38(9):4413-4429. PubMed ID: 28580693
[TBL] [Abstract][Full Text] [Related]
38. Speech-Language Pathologists' Use of Intelligibility Measures in Adults With Dysarthria.
Gurevich N; Scamihorn SL
Am J Speech Lang Pathol; 2017 Aug; 26(3):873-892. PubMed ID: 28772293
[TBL] [Abstract][Full Text] [Related]
39. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
[TBL] [Abstract][Full Text] [Related]
40. Immediate Effect of Stimulability Assessment on Acoustic, Aerodynamic, and Patient-Perceptual Measures of Voice.
Gillespie AI; Gartner-Schmidt J
J Voice; 2016 Jul; 30(4):507.e9-507.e14. PubMed ID: 26233832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
